Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients. [electronic resource]
Producer: 20080918Description: 287-95 p. digitalISSN:- 1473-0804
- Administration, Oral
- Aged
- Alendronate -- administration & dosage
- Alkaline Phosphatase
- Asian People
- Biomarkers -- urine
- Bone Density Conservation Agents -- administration & dosage
- Bone Remodeling -- drug effects
- Bone Resorption
- Bone and Bones -- enzymology
- Collagen Type I -- urine
- Etidronic Acid -- administration & dosage
- Female
- Humans
- Osteogenesis -- drug effects
- Osteoporosis, Postmenopausal -- drug therapy
- Parathyroid Hormone -- blood
- Peptides -- urine
- Prospective Studies
- Risedronic Acid
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.